Search Results for: PRRC2B

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel AK8 adenylate kinase 8
  • Interconversion of nucleotide di- and triphosphates
  • Bis(Adenosine)-5'-Pentaphosphate
Novel CFAP77 cilia and flagella associated protein 77
Novel DDX31 DEAD-box helicase 31
Novel GTF3C4 general transcription factor IIIC subunit 4
  • RNA Polymerase III Abortive And Retractive Initiation
  • RNA Polymerase III Transcription Initiation From Type 1 Promoter
  • RNA Polymerase III Transcription Initiation From Type 1 Promoter
  • RNA Polymerase III Transcription Initiation From Type 2 Promoter
  • RNA Polymerase III Transcription Initiation From Type 2 Promoter
Novel PLPP7 phospholipid phosphatase 7 (inactive)
Novel SETX senataxin
  • Ataxia with ocular apraxia (AOA), including: Ataxia telangiectasia (AT); Ataxia telangiectasia like disorder (ATLD); Ataxia oculomotor apraxia type 1 (AOA1); Ataxia oculomotor apraxia type 2 (AOA2)
  • Amyotrophic lateral sclerosis (ALS); Lou Gehrig's disease
  • Distal hereditary motor neuropathies (dHMN)
Novel UCK1 uridine-cytidine kinase 1
  • Pyrimidine salvage
ALG13 ALG13 UDP-N-acetylglucosaminyltransferase subunit
  • Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein
  • Defective ALG14 causes ALG14-CMS
ANKHD1 ankyrin repeat and KH domain containing 1
APP amyloid beta precursor protein
  • Platelet degranulation
  • ECM proteoglycans
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • G alpha (q) signalling events
  • G alpha (i) signalling events
  • Lysosome Vesicle Biogenesis
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • TAK1-dependent IKK and NF-kappa-B activation
  • The NLRP3 inflammasome
  • Advanced glycosylation endproduct receptor signaling
  • Advanced glycosylation endproduct receptor signaling
  • Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
  • Post-translational protein phosphorylation
  • TRAF6 mediated NF-kB activation
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Purinergic signaling in leishmaniasis infection
  • Amyloid fiber formation
  • Deferoxamine
  • Aluminium
  • Zinc
  • L-methionine (R)-S-oxide
  • Resveratrol
  • Tromethamine
  • Phenserine
  • Tetrathiomolybdate
  • CAD106
  • Mito-4509
  • Edonerpic
  • Dimercaprol
  • Copper
  • Florbetaben (18F)
  • Florbetapir (18F)
  • Flutemetamol (18F)
  • Gantenerumab
  • Aducanumab
  • Zinc acetate
  • Aluminium phosphate
  • Aluminum acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
  • Lecanemab
  • Alzheimer's disease (AD)
ATN1 atrophin 1
  • Regulation of PTEN gene transcription
  • Dentatorubropallidoluysian atrophy (DRPLA)
ATXN1 ataxin 1
  • Spinocerebellar ataxia (SCA); Machado-Joseph disease (SCA3)
ATXN1L ataxin 1 like
BAG4 BAG cochaperone 4
  • Regulation of HSF1-mediated heat shock response
  • Signaling by FGFR1 in disease
  • TNF signaling
  • Signaling by plasma membrane FGFR1 fusions
BCAS2 BCAS2 pre-mRNA processing factor
  • mRNA Splicing - Major Pathway
CRK CRK proto-oncogene, adaptor protein
  • ARMS-mediated activation
  • ARMS-mediated activation
  • Downstream signal transduction
  • Regulation of actin dynamics for phagocytic cup formation
  • p130Cas linkage to MAPK signaling for integrins
  • VEGFA-VEGFR2 Pathway
  • PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
  • MET activates RAP1 and RAC1
  • MET receptor recycling
  • Regulation of signaling by CBL
  • FCGR3A-mediated phagocytosis
CTBP1 C-terminal binding protein 1
  • Deactivation of the beta-catenin transactivating complex
  • SUMOylation of transcription cofactors
  • Repression of WNT target genes
  • Signaling by TCF7L2 mutants
  • Negative Regulation of CDH1 Gene Transcription
  • Formic acid
DAPK1 death associated protein kinase 1
  • Caspase activation via Dependence Receptors in the absence of ligand
  • 5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine
  • Phosphoaminophosphonic Acid-Adenylate Ester
  • 6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE
  • Fostamatinib
  • Bladder cancer
DDX11 DEAD/H-box helicase 11
  • XBP1(S) activates chaperone genes
  • Warsaw breakage syndrome
DIMT1 DIM1 rRNA methyltransferase and ribosome maturation factor
  • rRNA modification in the nucleus and cytosol

Page 1 out of 3 pages